Cho HJ: Difference between revisions
From Bioblast
Beno Marija (talk | contribs) (Created page with "{{Person |lastname=Cho |firstname=Hyun Ju |title= |institution=Inje University |address=633-165, Gaegeum-Dong, Busanjin-Gu |area code=614-735 |city=Busan |country=Republic o...") |
Beno Marija (talk | contribs) m (Beno Marija moved page Cho Hyun Ju to Cho HJ) |
(No difference)
|
Revision as of 12:12, 20 November 2018
Name | Cho Hyun Ju, |
---|---|
Institution | Inje University |
Address | 633-165, Gaegeum-Dong, Busanjin-Gu, 614-735 |
City | Busan |
State/Province | |
Country | Republic of Korea |
[email protected] | |
Weblink | |
O2k-Network Lab | KR Busan Han J |
Labels:
Publications
Published | Reference | |
---|---|---|
Shim 2022 Cancer Cell Int | 2022 | Shim JK, Choi S, Yoon SJ, Choi RJ, Park J, Lee EH, Cho HJ, Lee S, Teo WY, Moon JH, Kim HS, Kim EH, Cheong JH, Chang JH, Yook JI, Kang SG. (2022) Etomoxir, a carnitine palmitoyltransferase 1 inhibitor, combined with temozolomide reduces stemness and invasiveness in patient-derived glioblastoma tumorspheres. Cancer Cell Int 22:309. |